• 1.

    Genovese G, et al.. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841845.

  • 2.

    Stanescu HC, et al.. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364:616626.

  • 3.

    Kiryluk K, et al.. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 2014; 46:11871196.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Beck LH Jr., et al.. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:1121.

  • 5.

    Tomas NM, et al.. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371:22772287.

  • 6.

    Klein J, et al.. The role of urinary peptidomics in kidney disease research. Kidney Int 2016; 89:539545.

  • 7.

    Wada Y, et al.. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics 2010; 9:719727.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Takahashi K, et al.. Naturally occurring structural isomers in serum IgA1 O-glycosylation. J Proteome Res 2012; 11:692702.

  • 9.

    Kiryluk K, Novak J. The genetics and immunobiology of IgA nephropathy. J Clin Invest 2014; 124:23252332.

  • 10.

    Kiryluk K, et al.. GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway. PLoS Genet 2017; 13(2):e1006609.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Barrios C, et al.. Glycosylation profile of IgG in moderate kidney dysfunction. J Am Soc Nephrol 2016; 27:933941.

Advancing Our Understanding of Glomerular Disease Through Omics

Restricted access
Save